English
Home > Products > CAS:35380-71-3

China CAS:35380-71-3 Manufacturer

We hold strengthening and perfecting our items and repair. At the same time, we get the job done actively to do research and progress for CAS:35380-71-3, We welcome new and aged buyers from all walks of lifetime to make contact with us for potential small business associations and mutual success!
CAS:35380-71-3, Our company warmly invites domestic and overseas customers to come and negotiate business with us. Let us join hands to create a brilliant tomorrow! We're looking forward to cooperating with you sincerely to achieve a win-win situation. We promise to try our best to supply you with high quality and efficient services.

Related Products

Hot Products

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • Testosterone

    Testosterone

    Testosterone has CP,EP and USP specifications. CEP, DMF, WC, FDA available..

    CAS:58-22-0

  • Ethinyl Estradiol

    Ethinyl Estradiol

    Ethinyl Estradiol has USP, EP and CP specifications. DMF and GMP available.

    CAS:57-63-6

  • Revefenacin

    Revefenacin

    Revefenacin has In-house specification. DMF approved.

    CAS:864750-70-9

  • 21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

    21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

    21-Acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione is an intermediate in the synthesis of Budesonide (B689490) related derivatives.

    CAS:3044-42-6

  • Mifepristone Tablets

    Mifepristone Tablets

    Mifepristone Tablets Specifications：10mg*1
    Indications：Emergency Contraceptive
  • Related Blog
  • Reviews

  • Welcome to IPhEB Russia 2025

    ​IPhEB Russia 2025 will be held at EXPOFORUM Convention and Exhibition Centre from April 08-10,2025, our booth number is 320.

  • What are the categories of pharmaceutical intermediates?

    Pharmaceutical intermediates are classified by therapeutic areas, chemical structures, synthesis stages and production technologies, covering multiple types such as anti-tumor and anti-infection. They are key precursors in the synthesis of active pharmaceutical ingredients.

  • Visit us at CPHI Frankfurt - Booth 12.1C3!

    CPHI Frankfurt 2025 will be held at Messe Frankfurt from October 28 to 30, our booth number is 12.1C3.

  • How Can Intermediates Category Solutions Streamline Your Production Process

    As someone who has spent over two decades navigating the complexities of industrial production, I've seen firsthand how bottlenecks in the middle stages can derail entire operations. That’s why I was particularly impressed when I began working with solutions from the Intermediates Category. For any production manager, finding tools that seamlessly integrate and accelerate the core of your workflow is the ultimate goal. This is where the strategic approach from Humanwell truly shines, offering a refined path to efficiency that many of us have been searching for.

  • What Are Chemical Intermediates and How Are They Used in Pharmaceutical Manufacturing

    At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

  • Why Does an APIs Category Matter So Much When Choosing a Pharmaceutical Supplier?

    When buyers search for dependable pharmaceutical raw material partners, they often focus on price, lead time, and product availability first. In my experience, that approach can overlook a more important signal: how a supplier structures its APIs Category.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept